References
Basler RS (1985) Minocycline-related hyperpigmentation. Arch Dermatol 121:606–608
Dominic MR (2020) Adverse reactions induced by minocycline: a review of literature. Curr Drug Saf 16:1–13. https://doi.org/10.2174/1574886316666210120090446
Geria AN, Tajirian AL, Kihiczak G, Schwartz RA (2009) Minocycline-induced skin pigmentation: an update. Acta Dermatovenerol Croat 17:123–126
Mouton RW, Jordaan HF, Schneider JW (2004) A new type of minocycline-induced cutaneous hyperpigmentation. Clin Exp Dermatol 29:8–14
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Human and animal rights
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Min, Z., Saini, V., Mount, C.E. et al. Type II minocycline-induced cutaneous and scleral hyperpigmentation. Intern Emerg Med 17, 569–571 (2022). https://doi.org/10.1007/s11739-021-02853-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-021-02853-2